Spruce Street Capital Lp Portfolio Stock Holdings
Spruce Street Capital Lp disclosed 28 stock positions valued at approximately $415.9 million in its latest SEC 13F filing. The largest holdings include RELMADA THERAPEUTICS INC, DIANTHUS THERAPEUTICS IN, and RELAY THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 28
- Portfolio Value
- $415.9M
Holdings by Sector
Spruce Street Capital Lp Portfolio Holdings in Q1 2026
23 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 10.34% | 6,262,114 | +2,175,933 | +53.25% | $42,998,208 |
| DIANTHUS THERAPEUTICS IN | DNTH | Healthcare | 7.53% | 373,274 | +75,837 | +25.50% | $31,325,154 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 7.14% | 2,984,125 | - | - | $29,692,044 |
| ALTO NEUROSCIENCE INC | ANRO | Healthcare | 7.00% | 1,325,210 | +1,102,366 | +494.68% | $29,116,321 |
| CENTESSA PHARMACEUTICALS | CNTA | Healthcare | 4.68% | 489,849 | +411,852 | +528.04% | $19,456,802 |
| SAVARA INC | SVRA | Healthcare | 4.44% | 3,383,175 | +972,082 | +40.32% | $18,472,136 |
| KALVISTA PHARMACEUTICALS | KALV | Healthcare | 4.34% | 897,681 | +509,713 | +131.38% | $18,070,319 |
| VAXCYTE INC | PCVX | Healthcare | 3.43% | 245,709 | -154,651 | -38.63% | $14,278,150 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 3.10% | 329,006 | -117,078 | -26.25% | $12,897,035 |
| SURROZEN INC COM NEW | SRZN | Healthcare | 3.03% | 432,040 | - | - | $12,585,325 |
| ENANTA PHARMACEUTICALS I | ENTA | Healthcare | 2.83% | 932,598 | +542,911 | +139.32% | $11,778,713 |
| ALKERMES PLC | G01767105 | Other | 2.70% | 317,992 | +317,992 | +100.00% | $11,244,197 |
| PERSPECTIVE THERAPEUTICS | CATX | Healthcare | 2.63% | 2,627,107 | +2,627,107 | +100.00% | $10,955,036 |
| MINERVA NEUROSCIENC | NERV | Healthcare | 2.40% | 1,655,500 | - | - | $9,974,388 |
| CENTURY THERAPEUTICS | IPSC | Healthcare | 2.21% | 4,059,054 | +2,637,522 | +185.54% | $9,173,462 |
| ALUMIS INC | ALMS | Healthcare | 2.08% | 392,574 | +392,574 | +100.00% | $8,648,405 |
| SAB BIOTHERAPEUTICS IN | SABS | Healthcare | 2.02% | 2,198,502 | - | - | $8,420,263 |
| ERASCA INC | ERAS | Healthcare | 1.64% | 422,543 | -3,467,089 | -89.14% | $6,836,746 |
| INHIBIKASE THERAPEUTI | IKT | Healthcare | 1.45% | 3,581,603 | - | - | $6,017,093 |
| AN2 THERAPEUTICS INC | ANTX | Healthcare | 1.34% | 1,661,073 | +1,661,073 | +100.00% | $5,575,870 |
| LEXEO THERAPEUTICS INC | LXEO | Healthcare | 1.28% | 928,593 | +753,593 | +430.62% | $5,330,124 |
| ALECTOR INC | ALEC | Healthcare | 1.09% | 2,101,068 | +983,082 | +87.93% | $4,517,296 |
| CORVUS PHARMACEUTICALS I | CRVS | Healthcare | 0.81% | 231,585 | +231,585 | +100.00% | $3,388,089 |